🔓 Unlock the full profile of Preetish Toraskar (Koye Pharmaceuticals Pvt Ltd), including verified contact details, financial insights, and professional associations.
See Preetish Toraskar Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: pre*****@koy******.com
Mobile: 75641*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Preetish Toraskar is the Founder and Director of Koye Pharmaceuticals Pvt Ltd, which began operations in September 2013, reflecting a significant commitment to the pharmaceutical industry.
- Before founding Koye Pharmaceuticals, Toraskar served as Head of India Commercial Operations at Mylan, a position held from December 2011 until September 2013, where strategic decisions likely contributed to Mylan's growth in the Indian market.
- In July 2010, Toraskar was appointed as Senior Vice President of Sales and Marketing at Alkem Laboratories Ltd., where responsibilities included overseeing sales strategies and marketing initiatives, potentially driving revenue growth.
- Previous experience includes serving as Vice President for Sales and Marketing at Lupin Ltd. from March 2004 to July 2010, indicating a strong background in leadership and operational effectiveness within leading pharmaceutical firms.
- Before joining Lupin, Toraskar held a role as Marketing Manager at Novartis India Ltd. from January 2001 to January 2004, contributing valuable marketing insights in a competitive environment.
- Toraskar’s career began in 1995 as a Group Product Manager at Lupin Limited, showcasing an early aptitude for product management and marketing within the pharmaceutical sector.
- In 1993, prior to the corporate roles, Toraskar initiated a career in pharmaceuticals as a Marketing Executive at Cipla Ltd., Mumbai, laying the foundational experience in marketing strategies and execution.
- Throughout the career, Toraskar has demonstrated an ability to navigate the evolving landscape of the pharmaceutical industry, reflecting resilience and a strategic approach to market challenges.